ArticleiScience2024

Bispecific radioimmunoconjugates exploit receptor heterogeneity for positron emission tomography of tumors expressing HER2 and/or EGFR.

Luke Yongkyu Kwon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.